Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes
This article was originally published in The Tan Sheet
Executive Summary
FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen
You may also be interested in...
Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
Pharmaceutical firms are developing and reshaping their Rx-to-OTC switch strategies to remain competitive in an evolving industry where recent mergers and acquisitions underscore the importance of an OTC presence and switch platform
Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
Pharmaceutical firms are developing and reshaping their Rx-to-OTC switch strategies to remain competitive in an evolving industry where recent mergers and acquisitions underscore the importance of an OTC presence and switch platform
Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
Pharmaceutical firms are developing and reshaping their Rx-to-OTC switch strategies to remain competitive in an evolving industry where recent mergers and acquisitions underscore the importance of an OTC presence and switch platform